Secondaries announced 01.25.2017
IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. Company: Entellus Medical, Inc. Symbol: ENTL Price: Last trade $19.39 Description: Re-offer range $17.00-$18.00 Trade Date: 1/26 Shares: 3.1 million Underwriter(s)BofA Merrill[…]